Publications:

Pharmacogenomics and Personalized Medicine in Type 2 Diabetes Mellitus: Potential Implications for Clinical Practice.

Pharmacogenomics And Personalized Medicine

Venkatachalapathy, Poongothai P; Padhilahouse, Sruthi S; Sellappan, Mohan M; Subramanian, Tharunika T; Kurian, Shilia Jacob SJ; Miraj, Sonal Sekhar SS; Rao, Mahadev M; Raut, Ashwin Ashok AA; Kanwar, Rupinder Kaur RK; Singh, Jitendra J; Khadanga, Sagar S; Mondithoka, Sukumar S; Munisamy, Murali M

Publication Date: 2021

Variant appearance in text: rs2504927

PubMed Link: 34803393

Variant Present in the following documents:

• Main text
• pgpm-14-1441.pdf

View BVdb publication page

Metformin Pharmacogenetics: Effects of SLC22A1, SLC22A2, and SLC22A3 Polymorphisms on Glycemic Control and HbA1c Levels.

Journal Of Personalized Medicine

Al-Eitan, Laith N LN; Almomani, Basima A BA; Nassar, Ahmad M AM; Elsaqa, Barakat Z BZ; Saadeh, Nesreen A NA

Publication Date: 2019-03-25

Variant appearance in text: rs2504927

PubMed Link: 30934600

Variant Present in the following documents:

• Main text
• jpm-09-00017.pdf

View BVdb publication page

Genetic Variants Associated With Plasma Lipids Are Associated With the Lipid Response to Niacin.

Journal Of The American Heart Association

Tuteja, Sony S; Qu, Liming L; Vujkovic, Marijana M; Dunbar, Richard L RL; Chen, Jinbo J; DerOhannessian, Stephanie S; Rader, Daniel J DJ

Publication Date: 2018-10-02

Variant appearance in text: rs2504927

PubMed Link: 30371334

Variant Present in the following documents:

• Main text
• JAH3-7-0e03488.pdf

View BVdb publication page